Literature DB >> 19255795

ERGs in children with pancreatic enzyme insufficient and pancreatic enzyme sufficient cystic fibrosis.

Andrew Whatham1, Catherine Suttle, Caron Blumenthal, Jane Allen, Kevin Gaskin.   

Abstract

OBJECTIVES: We recorded scotopic and photopic flash electroretinograms (ERGs) in pediatric subjects with cystic fibrosis, aged 4 to 18 years, who were either pancreatic insufficient (PI) or pancreatic sufficient (PS). The aim of the study was to determine whether vitamin supplementation in the PI group allowed comparable retinal function in these two groups.
METHODS: ERGs were recorded from a mixed-gender group of 41 children and adolescents (4 to 17 years of age) with cystic fibrosis. The subjects were grouped according to pancreatic function into PI (n = 29) and PS (n = 12). Full-field flash ERGs were recorded from one eye using a DTL fiber. The pupil was dilated prior to recording using two drops of 0.5% tropicamide. ISCEV photopic and scotopic stimuli and recording conditions were used. Serum levels of vitamin A, beta carotene and retinol binding protein (RBP) were measured on the day of ERG recording.
RESULTS: There was no significant difference in ERG amplitudes or implicit times between PI and PS groups. Vitamin A, beta carotene, and RBP levels were not significantly different across the two groups and were not correlated with implicit times or amplitudes of any of the ERG types recorded here.
CONCLUSION: Similarity of ERGs across the PI and PS cystic fibrosis patient populations tested here suggests that the supplementation protocol applied to these populations allows similar levels of retinal function (as indicated by flash ERG parameters) in the two groups.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19255795     DOI: 10.1007/s10633-009-9168-7

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  22 in total

1.  Standard for clinical electroretinography (2004 update).

Authors:  Michael F Marmor; Graham E Holder; Mathias W Seeliger; Shuichi Yamamoto
Journal:  Doc Ophthalmol       Date:  2004-03       Impact factor: 2.379

2.  Visual evoked potentials standard (2004).

Authors:  J Vernon Odom; Michael Bach; Colin Barber; Mitchell Brigell; Michael F Marmor; Alma Patrizia Tormene; Graham E Holder
Journal:  Doc Ophthalmol       Date:  2004-03       Impact factor: 2.379

3.  Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen.

Authors:  A P Feranchak; M K Sontag; J S Wagener; K B Hammond; F J Accurso; R J Sokol
Journal:  J Pediatr       Date:  1999-11       Impact factor: 4.406

4.  Dark-adaptation testing for diagnosis of subclinical vitamin-A deficiency and evaluation of therapy.

Authors:  R M Russell; V C Smith; R Multack; A E Krill; I H Rosenberg
Journal:  Lancet       Date:  1973-11-24       Impact factor: 79.321

5.  Role of electroretinography in the assessment of retinal function as an indicator of vitamin A status.

Authors:  I Tsinopoulos; S Nousia-Arvanitakis; A Galli-Tsinopoulou; N Roubies; K Tentzidou; M Xefteri; N Stangos
Journal:  Doc Ophthalmol       Date:  2000-11       Impact factor: 2.379

6.  Loss of contrast sensitivity in cystic fibrosis.

Authors:  L E Leguire; K S Pappa; M L Kachmer; G L Rogers; D L Bremer
Journal:  Am J Ophthalmol       Date:  1991-04-15       Impact factor: 5.258

7.  Vitamin A deficiency and nocturnal vision in teenagers with cystic fibrosis.

Authors:  F Huet; D Semama; C Maingueneau; A Charavel; J L Nivelon
Journal:  Eur J Pediatr       Date:  1997-12       Impact factor: 3.183

8.  Age-specific reference intervals for plasma vitamins A, E and beta-carotene and for serum zinc, retinol-binding protein and prealbumin for Sydney children aged 9-62 months.

Authors:  M Karr; M Mira; J Causer; J Earl; G Alperstein; F Wood; M J Fett; J Coakley
Journal:  Int J Vitam Nutr Res       Date:  1997       Impact factor: 1.784

Review 9.  Electrophysiology in the investigation of acquired retinal disorders.

Authors:  H P Scholl; E Zrenner
Journal:  Surv Ophthalmol       Date:  2000 Jul-Aug       Impact factor: 6.048

10.  Ocular findings in cystic fibrosis patients receiving vitamin A supplementation.

Authors:  J C Morkeberg; C Edmund; J U Prause; S Lanng; C Koch; K F Michaelsen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-11       Impact factor: 3.117

View more
  1 in total

1.  Why bother to take vitamins?

Authors:  Alison Morton
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.